A carregar...
Does combined peroxisome proliferator-activated receptors-agonist and pravastatin therapy attenuate the onset of diabetes-induced experimental nephropathy?
OBJECTIVES: To investigate the combined effects of rosiglitazone and pravastatin on renal functions in early streptozotocin induced diabetic nephropathy (DN). METHODS: This study was carried out at King Khalid University Hospital Animal House, Riyadh, Saudi Arabia from August 2013 to February 2014....
Na minha lista:
| Publicado no: | Saudi Med J |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Saudi Medical Journal
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4362144/ https://ncbi.nlm.nih.gov/pubmed/25399210 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|